Preliminary Program Welcome – Agenda State of play with Vaccination Standards in Europe: an overview Christof Gessner, HL7 Europe Board of Directors, HL7 Germany What is the state of play of implementations across Europe? Role of HL7 Standards? Role of Affiliates? collaborations – decision-making practices – vendor engagement? Vaccination Standardization Efforts across Europe (deep dive, […]
UNICOM – EMA Implementation Guide v2.0 The course of IDMP implementation in Europe is strongly influenced by European Medicines Agency's (EMA) guidance. On Monday 22 February, EMA released version 2.0 of its Implementation guide (EU IG v2.0). This is a very important milestone for UNICOM and our communities, which will be presented and discussed at our […]
Understand the issues at stake and make your voice heard by attending the first UNICOM event targeted at national and European healthcare professionals and patients' organisations Download PDF Register NOW
The importance of medicinal product dictionaries (MPDs) is highlighted by two concrete examples. MPDs bring together the information on medicinal products from NCA and a variety of sources. Making sure that the identification of the medicinal product across these sources can be done automatically and without error, makes the implementation of IDMP such a crucial […]
UNICOM – Representation of clinical information related to medication using SNOMED CT and other standards This webinar will illustrate the use of SNOMED CT and other standards for the representation and use of clinical information in a select number of scenarios across the UNICOM landscape of IDMP implementation. The MHRA will demonstrate the use of SNOMED CT coded data in an actual electronic health […]
Initial roundtable discussion of groups involved in Adverse Events hosted by the FHIR Clinical Research Accelerator "Vulcan". Representatives from UNICOM T8.4 will "sit at the (round)table".
The meeting will update US key decision makers on the objectives and current achievements of UNCIOM and will open the way to to wider and more focused discussions on alignement possibilities. The EU UNICOM Trans-Atlantic Stakeholders Webinar will be officially coordinated by *CTADHL, a UNICOM partner formally tasked for trans-Atlantic outreach by UNICOM to include […]
Register here: https://connectathon.ihe-europe.net/connectathon/ihe-europe-experience
IDMP in Europe - what does it mean for you? Presentation by Robert Stegwee Free registration at: https://connectathon.ihe-europe.net/experience-sessions-tuesday-15-june
UNICOM – Cross-border ePrescription - standards, terminologies, processes You will learn what UNICOM is expected to contribute in order to make this service truly operational and reliable: The implementation of IDMP across Europe provides important opportunities for the improvement of cross-border services, such as ePrescription. UNICOM is tasked with elaborating these opportunities into change proposals […]
What is the relation between INN, ATC and substance identification according to IDMP? For the identification of substances, IDMP relies on data available in the Global Substance Registration System (GSRS). Its European counterpart EU-SRS is being implemented, supported by UNICOM WP 2, where an important data cleansing work is in progress. This webinar will cover the […]
The presentations will focus on the background, purpose, and governance of each of these identification and classification systems as well as their linkage. The discussion will also address how their use outside the originally defined scope may have consequences and limitations for the correct use of medicinal products across the countries. Presenters: Dr Rafaella Balocco […]
A medicine’s ePI ( Electronic Product Information) is regulated, scientifically validated information to assist healthcare professionals in prescribing and dispensing, and informs patients and consumers about their medicine and its safe use. Thus, trusted access and understanding of up-to-date product information on medicines when and where it is needed is extremely important. In Europe, the […]
Defining characteristics for dose forms, which meet global needs, is a challenge addressed by EDQM and several stakeholders. This webinar will present the views regarding the “global” aspect of dose form definition: in the regulatory space, in the clinical space, in the domain of adverse event monitoring and what efforts EDQM is deploying to meet […]
